X0306 4 2020-02-24 0000887247 Adamis Pharmaceuticals Corp ADMP 0001461736 Hopkins Robert O C/O ADAMIS PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, STE 300 SAN DIEGO CA 92130 false true false false Chief Financial Officer Common Stock 2020-02-24 4 S false 8420 0.6035 D 317480 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.615 to $0.608, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/Robert O. Hopkins, Power of Attorney for Robert O Hopkins 2020-02-26